Silver Book Fact

Fact image

Average direct medical costs over time, in 2001, for 194 participants in a community-based pharmaceutical care services program for patients with diabetes.

Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen. The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program. J Am Pharm Assoc. 2003; 43(2): 173-84. http://www.ncbi.nlm.nih.gov/pubmed/12688435

Reference

Title
The Asheville Project: Long-Term Clinical and Economic Outcomes of a Community Pharmacy Diabetes Care Program
Publication
J Am Pharm Assoc
Publication Date
2003
Authors
Cranor, Carole W., Barry A. Bunting, and Dale B. Christensen
Volume & Issue
Volume 43, Issue 2
Pages
173-84
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Economics of DR Treatment
    Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.  
  • Blood pressure control reduces the risk of cardiovascular disease (heart disease or stroke) among people with diabetes by 33% to 50%, and the risk of microvascular complications (eye, kidney, and…  
  • In a community pharmacy health management program called the Diabetes Ten City Challenge, in which 573 patients with diabetes participated, the average total healthcare costs per patient per year were…  
  • Medicines Reduce Complications of Diabetes: Diabetes patients treated with medicines are less likely to develop other health problems  
  • Mobile Exam for DR
    Use of a mobile examination for DR screening in Finland decreased visual impairment by 86% in the covered area.